Here are five facts:
1. U.S. patent number, 9,113,919, deals with the SImmetry Decorticator’s design.
2. The SImmetry Decorticator prepares the sacroiliac joint for fusion by clearing space for autologous bone graft and creating bleeding bone.
3. U.S. patent number, 9,101,371, describes a revision of a failed previous SI joint fusion surgery.
4. Revisions are necessary in spine surgery procedure development, so patients possess options for further treatments, if required.
5. With the addition of these two patents, Zyga holds 11 patents.
“These latest patents make IP claims in connection with our technology that underscore our commitment to advancing the field of SI joint fusion,” said Jim Bullock, Zyga president and CEO.
More articles on devices:
18 spine devices receive FDA 510(k) clearance in August
Ceterix receives FDA clearance for NovoStitch Plus: 5 key notes
Lawsuit filed against 3M and Arizant for surgical device — 5 key facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
